- Home
- HRZN vs TKNO Comparison
HRZN vs TKNO Comparison
Compare HRZN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRZN
- TKNO
- Stock Information
- Founded
- HRZN 2008
- TKNO 1996
- Country
- HRZN United States
- TKNO United States
- Employees
- HRZN N/A
- TKNO N/A
- Industry
- HRZN Finance/Investors Services
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- HRZN Finance
- TKNO Health Care
- Exchange
- HRZN Nasdaq
- TKNO Nasdaq
- Market Cap
- HRZN 352.9M
- TKNO 356.4M
- IPO Year
- HRZN 2010
- TKNO 2021
- Fundamental
- Price
- HRZN $8.18
- TKNO $4.40
- Analyst Decision
- HRZN Hold
- TKNO Buy
- Analyst Count
- HRZN 5
- TKNO 1
- Target Price
- HRZN $9.20
- TKNO $5.00
- AVG Volume (30 Days)
- HRZN 522.4K
- TKNO 318.7K
- Earning Date
- HRZN 07-29-2025
- TKNO 08-12-2025
- Dividend Yield
- HRZN 16.25%
- TKNO N/A
- EPS Growth
- HRZN N/A
- TKNO N/A
- EPS
- HRZN N/A
- TKNO N/A
- Revenue
- HRZN $98,302,000.00
- TKNO $38,250,000.00
- Revenue This Year
- HRZN $1.42
- TKNO $8.73
- Revenue Next Year
- HRZN $4.42
- TKNO $16.53
- P/E Ratio
- HRZN N/A
- TKNO N/A
- Revenue Growth
- HRZN N/A
- TKNO 3.79
- 52 Week Low
- HRZN $7.09
- TKNO $1.23
- 52 Week High
- HRZN $12.63
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- HRZN 72.52
- TKNO 29.05
- Support Level
- HRZN $7.09
- TKNO $4.90
- Resistance Level
- HRZN $7.42
- TKNO $5.38
- Average True Range (ATR)
- HRZN 0.19
- TKNO 0.33
- MACD
- HRZN 0.12
- TKNO -0.04
- Stochastic Oscillator
- HRZN 88.84
- TKNO 18.43
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.